Clinical Trial Update: Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Orteronel as maintenance therapy in metastatic castration-resistant prostate cancer previously treated with novel hormonal agents has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Orteronel (Orteronel)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 3 | Status: WITHDRAWN